Effect of IL-15 on IgG versus IgE antibody-secreting cells in vitro
Standard
Effect of IL-15 on IgG versus IgE antibody-secreting cells in vitro. / Esen, Meral; Forster, Johannes; Ajua, Anthony; Spänkuch, Iris; Paparoupa, Maria; Mordmüller, Benjamin; Kremsner, Peter G.
In: J IMMUNOL METHODS, Vol. 375, No. 1-2, 31.01.2012, p. 7-13.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Effect of IL-15 on IgG versus IgE antibody-secreting cells in vitro
AU - Esen, Meral
AU - Forster, Johannes
AU - Ajua, Anthony
AU - Spänkuch, Iris
AU - Paparoupa, Maria
AU - Mordmüller, Benjamin
AU - Kremsner, Peter G
N1 - Copyright © 2011 Elsevier B.V. All rights reserved.
PY - 2012/1/31
Y1 - 2012/1/31
N2 - Immunoglobulin E (IgE) antibodies are major contributors to the pathology of atopic and allergic diseases as well as to immune response to helminth infections. Development of an adequate immunoglobulin G (IgG) immune response against infectious agents and vaccine antigens is considered in most cases as crucial for protection from disease. In vivo and in vitro production of IgE and IgG depends on cytokines and other soluble factors. Recently it has been shown that IgG antibody secreting cells (ASCs) can be generated by in vitro maturation of blood cells with Interleukin- (IL-)15 and CpG DNA or other stimulation cocktails, while IgE-ASCs develop upon cultivation with anti-CD40 and IL-4. In the present study we employed an enzyme linked immunospot assay (ELISPOT) to assess the capacity of individuals to develop into either IgE-ASCs or IgG-ASCs upon stimulation with different combinations of stimulation cocktails in order to investigate the influence of cytokines that are dysregulated in IgE-mediated immune reactions on ASC generation. Furthermore, we modified the method to assess IgG- and IgE-ASCs specific for two model antigens causing allergic rhinitis in humans. We demonstrate that IL-15, which is important for development of IgG-ASCs, decreases the number of IgE-ASCs when added to media commonly used for in vitro development of IgE-ASCs. We show that our method is suitable for the detection of specific and non-specific IgE-ASCs and IgG-ASCs and allows the investigation of the interplay between IgG-ASCs and IgE-ASCs in different populations.
AB - Immunoglobulin E (IgE) antibodies are major contributors to the pathology of atopic and allergic diseases as well as to immune response to helminth infections. Development of an adequate immunoglobulin G (IgG) immune response against infectious agents and vaccine antigens is considered in most cases as crucial for protection from disease. In vivo and in vitro production of IgE and IgG depends on cytokines and other soluble factors. Recently it has been shown that IgG antibody secreting cells (ASCs) can be generated by in vitro maturation of blood cells with Interleukin- (IL-)15 and CpG DNA or other stimulation cocktails, while IgE-ASCs develop upon cultivation with anti-CD40 and IL-4. In the present study we employed an enzyme linked immunospot assay (ELISPOT) to assess the capacity of individuals to develop into either IgE-ASCs or IgG-ASCs upon stimulation with different combinations of stimulation cocktails in order to investigate the influence of cytokines that are dysregulated in IgE-mediated immune reactions on ASC generation. Furthermore, we modified the method to assess IgG- and IgE-ASCs specific for two model antigens causing allergic rhinitis in humans. We demonstrate that IL-15, which is important for development of IgG-ASCs, decreases the number of IgE-ASCs when added to media commonly used for in vitro development of IgE-ASCs. We show that our method is suitable for the detection of specific and non-specific IgE-ASCs and IgG-ASCs and allows the investigation of the interplay between IgG-ASCs and IgE-ASCs in different populations.
KW - Adult
KW - Antibody-Producing Cells
KW - B-Lymphocytes
KW - Enzyme-Linked Immunospot Assay
KW - Humans
KW - Immunoglobulin E
KW - Immunoglobulin G
KW - Immunologic Factors
KW - Interleukin-15
KW - Interleukins
KW - Middle Aged
KW - Rhinitis, Allergic, Seasonal
KW - Young Adult
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
U2 - 10.1016/j.jim.2011.08.020
DO - 10.1016/j.jim.2011.08.020
M3 - SCORING: Journal article
C2 - 21945396
VL - 375
SP - 7
EP - 13
JO - J IMMUNOL METHODS
JF - J IMMUNOL METHODS
SN - 0022-1759
IS - 1-2
ER -